Trump strikes big pharma deal: Wegovy & Zepbound prices slashed for millions of Americans
Published on Nov 07, 2025 02:05 am IST
President Donald Trump has announced a major deal with Eli Lilly and Novo Nordisk to expand coverage and reduce prices for their blockbuster obesity drugs, Zepbound and Wegovy. These GLP-1 treatments, known for their effectiveness in weight loss, have been out of reach for many Americans due to high costs and limited insurance coverage. Starting next year, Medicare will cover the drugs, and new lower-priced pill versions could cost as little as $149 a month. The move marks Trump’s latest push to tackle rising healthcare costs and inflation concerns. Will this reshape America’s health landscape?
RELATED VIDEOS
Ancient Mammoth Skeleton Discovered Along Bulgaria's Drought-Hit Danube
Published on Jul 30, 2026 11:12 am IST
Drone Attack Targets U.S.-Owned Tanker at Egypt's Mediterranean Port
Published on Jul 30, 2026 10:42 am IST
Spain's Zamora Wildfires Intensify As Firefighters Race To Contain Flames
Published on Jul 30, 2026 09:57 am IST
Infantino Defends FIFA's Proposed World Cup Investment Strategy
Published on Jul 30, 2026 09:57 am IST
Top Putin aide paints Baltic states as frontline threat to Russia
Published on Jul 30, 2026 09:54 am IST
Putin aide declares Zelensky now fights Russia with terror tactics
Published on Jul 30, 2026 09:51 am IST
Hi, {{name}}
Sign out
{{planName}}
{{^userSubscribed}}
{{/userSubscribed}}